Ingrid Robidas retweeted
#Pembrolizumab becomes first anti-PD-1 drug approved for patients w/advanced melanoma. nyti.ms/1nz9Y57 #immunotherapy #cancer
Ingrid Robidas retweeted
Two Immuno-Oncology deals before #ASCO14 abs
$AZN PD-L1 + $INCY IDO
finance.yahoo.com/news/incyt…
$BMY PD1 + $CLDX CD27
finance.yahoo.com/news/brist…
Ingrid Robidas retweeted
A revival for a risky cancer therapy? #ASCO14 preview by @heidiledford nature.com/news/old-cancer-d…
Ingrid Robidas retweeted
POV from Dan Chen on why immunotherapy is one of the most promising cancer approaches #ASCO14 ow.ly/xmQTb
Ingrid Robidas retweeted
Ellis: approaches to profiling cancers #asco14 combo tx session
Ingrid Robidas retweeted
How a new treatment using a person's immune cells is helping to fight cervical cancer. nbcnews.to/1l3TAv0 #cancer #ASCO14







